Fig. 1.
Fig. 1. TRM. / (A) Evolution of the early TRM risk according to the speed of neutrophil recovery (···· indicates 95% confidence interval of the risk). An increasing risk for transplantation-related death was observed when neutrophil recovery was rapidly achieved, that is, before day 22. (B) Patients who received BM grafts had early TRM of 7% and 9% if they reached an absolute neutrophil count greater than or equal to .5 × 109/L before day 22 (· · · ·) and thereafter (), respectively. Patients who received PBPCs had early TRM of 21% and 0% if they had reached an absolute neutrophil count greater than or equal to .5 × 109/L before day 22 (---) and thereafter (—), respectively. (C) Patients who received BM grafts () had late TRM of 36% compared with 42% for those who received PBPCs (---) (P = .32). (D) Patients with RAEB or RAEB-t at last disease evaluation and no high-risk cytogenetics (n = 82) had a 2-year TRM of 19% with PBPCs (---) compared with 39% with BM () (P < .05).

TRM.

(A) Evolution of the early TRM risk according to the speed of neutrophil recovery (···· indicates 95% confidence interval of the risk). An increasing risk for transplantation-related death was observed when neutrophil recovery was rapidly achieved, that is, before day 22. (B) Patients who received BM grafts had early TRM of 7% and 9% if they reached an absolute neutrophil count greater than or equal to .5 × 109/L before day 22 (· · · ·) and thereafter (), respectively. Patients who received PBPCs had early TRM of 21% and 0% if they had reached an absolute neutrophil count greater than or equal to .5 × 109/L before day 22 (---) and thereafter (), respectively. (C) Patients who received BM grafts () had late TRM of 36% compared with 42% for those who received PBPCs (---) (P = .32). (D) Patients with RAEB or RAEB-t at last disease evaluation and no high-risk cytogenetics (n = 82) had a 2-year TRM of 19% with PBPCs (---) compared with 39% with BM () (P < .05).

Close Modal

or Create an Account

Close Modal
Close Modal